TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TECH

Bio-Techne Corp

Healthcare · Biotechnology

72.40$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 1,215 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TECH
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
452 499 563 643 714 739 931 1,106 1,137 1,159 1,220 1,215
145 162 188 211 241 255 298 349 367 389 429 416
307 337 375 432 473 483 633 756 770 770 790 799
41 45 54 55 62 65 71 87 92 97 99 95
119 141 153 241 237 241 290 339 352 393 415 452
160 186 253 296 327 326 396 460 471 563 688 547
147 151 122 136 126 157 237 297 299 207 102 252
1.5 1.7 7.4 10 22 19 14 11 11 16 8.5 5.4
154 147 113 126 112 276 148 301 339 186 98 241
46 43 36 0.6 16 47 8.6 38 53 18 25 59
108 104 77 125 96 229 140 272 285 168 73 182
184 193 182 201 212 378 250 414 457 313 217 343

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?